Merck and Japan-based Eisai said on Friday a combination of their therapies failed to extend the lives of patients with a ...

Eli Lilly and Merck & Co. are partnering with Purdue University to launch the Young Institute Pharmaceutical Manufacturing ...

Merck stock (NYSE: MRK) lost about 10% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year. Despite strong performances from other pharmaceutical giants like Eli ...

Photo shows Rutgers Full-Time MBA student Abha Mehta sitting on steps inside Rutgers Business School in Newark. The Full-Time ...

Robert F. Kennedy Jr., President Trump’s nominee to be health secretary, would have oversight power over the vaccine’s maker, Merck, if confirmed. By Christina Jewett and Sheryl Gay Stolberg ...

In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against Prem Watsa’s other long-term stock picks. Prem Watsa is a Canadian billionaire, entrepreneur ...

Even if Robert F. Kennedy Jr. is confirmed as the next Health and Human Services secretary, he still plans to collect fees from Wisner Baum, a law firm suing Merck over claims that the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The old campus borders the Rancocas Creek, sits in the New Jersey Pinelands and has remained mostly vacant for seven years. “We are taking this action to remove blight and protect public safety ...

Shares in Moderna were ticking upwards today after Merck & Co took up an option on a personalised RNA-based cancer vaccine with a payment of $250 million. It is the first time that Merck has ...

The Buffalo and Erie County Industrial Land Development Corp. chose Asbury-based J.G. Petrucci Co. to take on the agency's request for construction of at least 200,000 square feet of new space.

Merck, known as MSD outside the United States and Canada announced that the Food and Drug Administration (FDA) has approved two new HIV-1 medicines: Delstrigo and Pifeltro.